https://www.live-feeds.com/feed/moderna-ceo-on-what-s-next-after-success-in-cancer-vaccineContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/moderna-ceo-on-what-s-next-after-success-in-cancer-vaccinehttps://www.live-feeds.com/feed/moderna-ceo-on-what-s-next-after-success-in-cancer-vaccine#u162585Fri, 30 Oct 2026 03:50:28 +0000Moderna's CEO Stéphane Bancel discussed the company's plans following the success of its cancer vaccine, particularly in treating melanoma. The vaccine has shown significant promise in reducing the risk of cancer recurrence. Bancel expressed confidence in the vaccine's potential beyond melanoma.Why it mattersModerna's cancer vaccine has been a significant breakthrough in the field of oncology. The vaccine uses mRNA technology to help the body's immune system recognize and attack cancer cells. This development has generated considerable interest and hope for cancer trea